LTX-315 – A Promising Novel Antitumor Peptide and Immunotherapeutic Agent

Cell Stress
doi 10.15698/cst2019.11.202
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Shared Science Publishers OG

Related search

Discovery of a 9-Mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2016English

Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk Between Invariant NKT Cells and Dendritic Cells

Frontiers in Immunology
AllergyImmunology
2017English

TAS-102, a Novel Antitumor Agent: A Review of the Mechanism of Action

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2015English

Complete Regression and Systemic Protective Immune Responses Obtained in B16 Melanomas After Treatment With LTX-315

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2014English

Propafenone: A Promising New Antiarrhythmic Agent

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1990English

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers

Hereditary Genetics
2012English

The Synthetic Antimicrobial Peptide LTX 21 Induces Inflammatory Responses in a Human Whole Blood Model and a Murine Peritoneum Model

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2019English

Cyclotides, a Promising Molecular Scaffold for Peptide-Based Therapeutics

Biopolymers
BiochemistryMedicineBiomaterialsOrganic ChemistryBiophysics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy